Please login to the form below
heart attack
This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk set to acquire Emisphere Technology for $1.8bn
such as heart attack, stroke or death in adults with type 2 diabetes with known heart disease.
Latest news
-
AstraZeneca’s Farxiga scores another FDA fast-track designation
or cardiovascular death in adult following an acute myocardial infarction or heart attack. ... secondary prevention of cardiovascular events among high-risk patients who have experienced a heart attack.
-
AstraZeneca’s Brilinta reduces rate of secondary stroke
heart attack and/or death when given to patients who had previously suffered a stroke or transient transient ischaemic attack. ... The drug is already approved for the treatment of acute coronary syndrome (ACS) and for the secondary prevention of
-
Amarin shares tumble following Vascepa patent loss
treating indicated patients at high risk of cardiovascular events, such as heart attack and stroke,” said Thero.
-
Novartis plans inclisiran trial in the UK
Novartis also plans to conduct ORION-4, the ongoing study for patients who have already had a heart attack or stroke, with this study making the UK the global trial centre.
-
AZ says Brilinta hits the mark in new stroke trial
When used on its own by patients who had already suffered a stroke or transient ischaemic attack (TIA), it demonstrated a trend towards fewer subsequent events of stroke, heart attack ... The drug is already approved for the treatment of acute coronary
AstraZeneca’s Farxiga scores another FDA fast-track designation
AstraZeneca’s Brilinta reduces rate of secondary stroke
Amarin shares tumble following Vascepa patent loss
Novartis plans inclisiran trial in the UK
AZ says Brilinta hits the mark in new stroke trial
More from news
Approximately 5 fully matching, plus 224 partially matching documents found.
Latest Intelligence
-
The evolution of marketing – the Amgen way
Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable. ... predict which cardiovascular disease patients are at high risk of a second event, such as a heart attack
-
Changing direction: adapting to a rapidly-evolving environment
In the era of the algorithm, your doctor can now predict you’ll have a fatal heart attack five years before it hits you. ... If we’re going to exploit the brilliance of technology to change behaviours and transform health outcomes, marketing and
-
Insights from Cannes Lions Health Festival 2018
sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
-
Proving real-world value
Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
-
Why health psychology is the answer to tackling adherence
Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.
The evolution of marketing – the Amgen way
Changing direction: adapting to a rapidly-evolving environment
Insights from Cannes Lions Health Festival 2018
Proving real-world value
Why health psychology is the answer to tackling adherence
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Addressing the Gendered Health Data Gap
Take heart attacks for example, the British Heart Foundation found women are 50% more likely to be misdiagnosed following a heart attack. ... One of the routine tests to diagnose a heart attack is the troponin test used to identify damage to heart cells.
-
#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
For example, women experience different symptoms for heart attacks than men. ... It’s likely that this contributes to the fact that women are more likely to die within the first year of having a heart attack.
-
World Heart Day 2020: It's time to make our clinical trials more inclusive
One study found the average time for a South Asian patient to receive treatment for a heart attack was nearly double compared with a white person. ... For example, one study found that centrally located pain is symbolic of a heart attack in 87% white
-
Covid-19: what could it mean for the diabetic population?
a heart attack and twice as likely to have a stroke than people who do not have the condition. This, combined with the vast number of people affected by the disease,
-
Hanover Communications
For example, women are 50% more likely to be misdiagnosed following a heart attack because participation in clinical trials is generally skewed towards males.
Addressing the Gendered Health Data Gap
#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
World Heart Day 2020: It's time to make our clinical trials more inclusive
Hanover Communications
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital strategist
-
Competitive
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Digital account director
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- GSK reveals plans for £400m R&D facility expansion in England
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
